Results 311 to 320 of about 22,534,193 (360)
Some of the next articles are maybe not open access.
Current Opinion in Supportive & Palliative Care, 2010
To provide an overview of issues central to hydration in an oncology population while highlighting recent advances and publications in the clinical and scientific literature.Dehydration accounts for a significant number of unplanned visits to cancer clinics and emergency rooms.
openaire +2 more sources
To provide an overview of issues central to hydration in an oncology population while highlighting recent advances and publications in the clinical and scientific literature.Dehydration accounts for a significant number of unplanned visits to cancer clinics and emergency rooms.
openaire +2 more sources
New England Journal of Medicine, 1973
Abstract Analysis was made of psychosocial factors influencing the amount of elapsed time between the first sign or symptom of cancer and the search for medical help in 563 patients.
T P, Hackett, N H, Cassem, J W, Raker
openaire +2 more sources
Abstract Analysis was made of psychosocial factors influencing the amount of elapsed time between the first sign or symptom of cancer and the search for medical help in 563 patients.
T P, Hackett, N H, Cassem, J W, Raker
openaire +2 more sources
The Lancet Oncology, 2001
Clinical depression is a relatively common, and yet frequently overlooked, source of suffering among patients with cancer. All patients who face a life-threatening diagnosis such as cancer experience a normal albeit painful emotional reaction, but a substantial minority will become clinically depressed.
openaire +2 more sources
Clinical depression is a relatively common, and yet frequently overlooked, source of suffering among patients with cancer. All patients who face a life-threatening diagnosis such as cancer experience a normal albeit painful emotional reaction, but a substantial minority will become clinically depressed.
openaire +2 more sources
Immunostimulation in Cancer Patients
1983It is interesting to treat cancer patients by the potentiation of their depressed immune status. There are many immunopotentiators which showed potent antitumor activity in experimental tumor systems in vivo and in vitro, however, which were not always effective in well-designed controlled clinical trials. At the present time, we should say that cancer
Y, Yamamura, I, Azuma
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1979
To the Editor.— The article by Novack et al (241:897, 1979), "Changes in Physicians' Attitudes Toward Telling the Cancer Patient," was an important one. Properly, it evoked two editorials (241:928, 1979) that appeared in the same issue. However, the conclusions of the article and both of the editorials were bone chilling.
openaire +2 more sources
To the Editor.— The article by Novack et al (241:897, 1979), "Changes in Physicians' Attitudes Toward Telling the Cancer Patient," was an important one. Properly, it evoked two editorials (241:928, 1979) that appeared in the same issue. However, the conclusions of the article and both of the editorials were bone chilling.
openaire +2 more sources
Thrombocytopenia in cancer patients
Thrombosis Research, 2014Thrombocytopenia is a frequent complication of cancer and its treatment. The causes of thrombocytopenia in cancer patients can be diverse and multifactorial. Systemic chemotherapy is the most frequent cause of thrombocytopenia. The degree and duration thrombocytopenia depends upon whether the chemotherapeutic treatment is myeloablative, as used in stem
openaire +2 more sources